Systemic Profile of Cytokines in Arteriovenous Fistula Patients and Their Associations with Maturation Failure

Kidney360. 2022 Jan 13;3(4):677-686. doi: 10.34067/KID.0006022021. eCollection 2022 Apr 28.

Abstract

Background: Systemic cytokines are elevated in patients with chronic kidney disease (CKD) and on hemodialysis compared with the general population. However, whether cytokine levels interfere with vascular remodeling, increasing the risk of arteriovenous fistula (AVF) failure, remains unknown.

Methods: This is a case-control study of 64 patients who underwent surgery for AVF creation (32 with AVF maturation failure and 32 matching controls with successful maturation). A total of 74 cytokines, including chemokines, interferons, interleukins, and growth factors, were measured in preoperative plasma samples using multiplex assays. Sixty-two patients were included in the statistical analyses. Associations with AVF failure were assessed using paired comparisons and conditional logistic regressions accounting for paired strata.

Results: Seven cytokines were significantly higher in patients with AVF maturation failure than in matching controls (G-CSF, IL-6, MDC, RANTES, SDF-1α/β, TGFα, and TPO). Of these, G-CSF (odds ratio [OR]=1.71; 95% confidence interval [95% CI], 1.05 to 2.79 per 10 pg/ml), MDC (OR=1.60, 95% CI, 1.08 to 2.38 per 100 pg/ml), RANTES (OR=1.55, 95% CI, 1.10 to 2.17 per 100 pg/ml), SDF-1α/β (OR=1.18, 95% CI, 1.04 to 1.33 per 1000 pg/ml), and TGFα (OR=1.39, 95% CI 1.003, 1.92 per 1 pg/ml) showed an incremental association by logistic regression.

Conclusions: This study identified a profile of plasma cytokines associated with adverse maturation outcomes in AVFs. These findings may open the doors for future therapeutics and markers for risk stratification.

Keywords: arteriovenous fistula; chronic kidney disease; cytokine; dialysis; inflammation.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, N.I.H., Extramural

MeSH terms

  • Arteriovenous Fistula* / etiology
  • Arteriovenous Shunt, Surgical* / adverse effects
  • Case-Control Studies
  • Chemokine CCL5
  • Chemokine CXCL12
  • Cytokines
  • Granulocyte Colony-Stimulating Factor
  • Humans
  • Transforming Growth Factor alpha

Substances

  • Chemokine CCL5
  • Chemokine CXCL12
  • Cytokines
  • Transforming Growth Factor alpha
  • Granulocyte Colony-Stimulating Factor